Acanthosis nigricans and obesity, an endocrine abnormality?
D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D015068:17-Ketosteroids / Q000378:metabolism; D000052:Acanthosis Nigricans / Q000150:complications / Q000209:etiology*; D000307:Adrenal Gland Diseases / Q000150:complications; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D004700:Endocrine System Diseases / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D009765:Obesity / Q000150:complications / Q000209:etiology*; D010900:Pituitary Diseases / Q000150:complications; D013256:Steroids / Q000378:metabolism
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D013256:Steroids; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone